Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-069210
Filing Date
2025-05-12
Accepted
2025-05-12 16:11:34
Documents
62
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arct-20250331.htm   iXBRL 10-Q 1336371
2 EX-10.36 arct-ex10_36.htm EX-10.36 36841
3 EX-31.1 arct-ex31_1.htm EX-31.1 17013
4 EX-31.2 arct-ex31_2.htm EX-31.2 16971
5 EX-32.1 arct-ex32_1.htm EX-32.1 9410
6 EX-32.2 arct-ex32_2.htm EX-32.2 9379
7 GRAPHIC img165162168_0.jpg GRAPHIC 10855
8 GRAPHIC img165162168_1.jpg GRAPHIC 10855
9 GRAPHIC img165162168_2.jpg GRAPHIC 11298
10 GRAPHIC img268084525_0.jpg GRAPHIC 64836
11 GRAPHIC img268084525_1.jpg GRAPHIC 59465
  Complete submission text file 0000950170-25-069210.txt   6053718

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT arct-20250331.xsd EX-101.SCH 980073
64 EXTRACTED XBRL INSTANCE DOCUMENT arct-20250331_htm.xml XML 752314
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38942 | Film No.: 25934929
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)